Keywords: Influenza; Brazil; Cost-effectiveness; Vaccination; QIV; TIV;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Influenza; Cost-effectiveness; Vaccination; Trivalent; Quadrivalent; Dynamic transmission model; GDP; gross domestic product; ICER; incremental cost-effectiveness ratio; HIV; human immunodeficiency virus; IBS; individual based simulation; I$; internationa
Keywords: ASC; Antibody Secreting Cells; ELISPOT; Enzyme-Linked Immunospot; FT; Full-Term; GA; Gestational Age; HAI; Hemagglutination Inhibition; LLPC; Long-Lived Plasma Cells; PBMC; Peripheral Blood Mononuclear Cell; PT; Preterm; QIV; Quadravalent Inactivated Infl
Keywords: Influenza vaccine; Quadrivalent; Immunogenicity; QIV; Intramuscular;
Keywords: ACIP; Advisory Committee on Immunization Practices; ADEM; acute disseminated encephalomyelitis; AE; adverse events; AIDP; acute inflammatory demyelinating polyradiculoneuropathy; AMAN; acute motor axonal neuropathy; AMSAN; acute motor and sensory neuropat
Rationale for two influenza B lineages in seasonal vaccines: A meta-regression study on immunogenicity and controlled field trials
Keywords: Influenza B virus; Influenza vaccine; Vaccine effectiveness; Influenza B lineage mismatch; Pre-seasonal immunity; Meta-analysis; Meta-regression; Ab; antibody, or predicted from antibody; CI; confidence interval; Fab; antibody density function; FCP; clini
Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France)
Keywords: BMFG; Bill & Melinda Gates Foundation; GABRIEL; global approach to biological research on infectious epidemics in low-income countries network; Hib; Haemophilus influenzae type b; HIV; human immunodeficiency virus; LAIV; live attenuated influenza vaccine;